Featured
CSL Seqirus

Auditor - GVP

4 days ago by CSL Seqirus
  • Salary negotiable
  • Maidenhead, England, UK
  • Full-time
Typical response: within 5 days Secure 1-click apply No spam — we never sell your data
AI summary

GVP Auditor role within CSL Seqirus’ R&D Quality audit program, executing the global audit plan across internal pharmacovigilance functions and external PV partners. You’ll lead audits, write risk-based reports, drive CAPAs, and identify compliance trends to protect safety data integrity and the PV system. CSL Seqirus is a major global influenza vaccine provider, and the standout perk is a global remit with up to 50% travel.

Key skills
GVP (Good Pharmacovigilance Practices) auditingPharmacovigilance (PV) quality assuranceAudit report writing and risk categorisationCAPA (Corrective and Preventive Actions)EMA GVP Modules (I–XVI)ICH E2A / E2B(R3) / E2C(R2) / E2D(R1) / E2F21 CFR Part 314.80 and 21 CFR Part 600 Subpart DDirective 2001/83/EC and Regulation (EC) No 726/2004
Salary not listed — comparable Maidenhead/London-area GVP Auditor roles typically pay ~£55k–£75k depending on experience and travel scope.
You'll thrive here if you’re an experienced PV/QA auditor who can independently run global GVP audits, communicate findings clearly, and partner with stakeholders to deliver effective CAPAs.
Why apply
  • Global audit remit across PV
  • Major influenza vaccine provider
  • Up to 50% travel
Quality in a globalized drug safety network is a matter of operational resilience as much as regulatory mandate. This role serves as a

GVP

Auditor

within our Research & Development Quality audit program, responsible for executing the global audit plan to ensure the accuracy of safety data and compliance with legal and corporate standards. By conducting audits of our external partners and internal safety functions, you identify the findings and non-compliance trends that could

impact

the reliability of our pharmacovigilance system. We are looking for an experienced auditor who can navigate complex safety environments and work collaboratively with stakeholders to develop corrective actions that ensure long-term systemic stability.

Main Responsibilities Audit Execution:

Conduct assigned external audits of pharmacovigilance vendors and service providers, as well as internal self-inspections of safety processes,

systems

, and

affiliates

(

including

Local

/Regional Safety Officers (LSO/RSOs)

activities)

. Reporting & Risk Categorization:

Develop and issue comprehensive Audit Reports, categorizing findings by risk level and providing recommendations for corrective and preventive actions (CAPA) related to drug safety. Trend Analysis:

Identify non-compliance trends and systematic risks within the PV discipline, communicating these findings to line management and functional leads to

support PV system health and

protect

the integrity of the PSMF documenting it

. Continuous Improvement:

Support initiatives to improve standard operating procedures (SOPs) for audit conduct and partner with stakeholders to develop risk-based, compliant solutions

that ensure compliance with EMA Guidelines on Good Pharmacovigilance Practices (GVP Modules), and applicable global and local regulatory

requirements.

. Regulatory Knowledge:

Maintain up-to-date knowledge of global GVP regulations (Good Pharmacovigilance Practices) and industry trends,

to support internal quality and compliance

.

Position Qualifications & Experience Academic Background:

BS degree in a relevant biological science, pharmacy, or related science discipline.

Professional Experience:

Quality Assurance experience within a GVP-regulated environment, demonstrating a strong understanding of drug safety operations and regulatory frameworks.

Audit Expertise:

Experience in audit and inspection management, with a clear understanding of the requirements for quality assurance in the pharmacovigilance discipline.

Communication Skills:

Excellent interpersonal and negotiation skills, with the ability to work effectively with multinational teams and external

stakeholders

across different regions.

Working Knowledge of:

ICH

E2D(R1)

,

E2A, E2B(R3), E2C(R2),

and

E2F

Guideline

s

21 CFR Part

314

.80 (for drugs)

, 21 CFR

Part 600 Subpart D (for biologics)

and 21 CFR Part 4 (Combination prod

uct/duplicate reporting prevention)

Directive 2001/83/EC (as amended)

Regulation (EC) No 726/2004

Commission Implementing Regulation (EU) No 520/2012

EMA GVP Modules (I–XVI + product/population-specific modules)

Organizational Agility:

Strong analytical and problem-solving skills, with the ability to work with limited supervision and manage a schedule that includes up

to

50% travel

.

About CSL Seqirus

CSL Seqirus is part of CSL. As one of the largest influenza vaccine providers in the world, CSL Seqirus is a major contributor to the prevention of influenza globally and a transcontinental partner in pandemic preparedness. With state-of-the-art production facilities in the U.S., the U.K. and Australia, CSL Seqirus utilizes egg, cell and adjuvant technologies to offer a broad portfolio of differentiated influenza vaccines in more than 20 countries around the world. To learn more about CSL, CSL Behring, CSL Seqirus and CSL Vifor visit

and CSL Plasma at

.

Our Benefits For more information on CSL benefits visit

How CSL Supports Your Well-being | CSL

.

You Belong at CSL At CSL, Inclusion and Belonging is at the core of our mission and who we are. It fuels our innovation day in and day out. By celebrating our differences and creating a culture of curiosity and empathy, we are able to better understand and connect with our patients and donors, foster strong relationships with our stakeholders, and sustain a diverse workforce that will move our company and industry into the future. To learn more about inclusion and belonging visit careers/inclusion-and-belonging

Equal Opportunity Employer CSL is an Equal Opportunity Employer. If you are an individual with a disability and need a reasonable accommodation for any part of the application process, please visit

accessibility-statement

.

Watch our ‘On the Front Line’ video to learn more about CSL Seqirus

Reference: 23810_2735653287·Original posting
Related

You might also like

Made with Emergent